Lubaton, Rosalinda A.
HRN: 01-34-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/10/2023
03/17/2023
IV
4.5g
Q6
Septic Shock
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes